Mutational and Functional Impact of β-globin Gene Mutation in Indonesian Thalassemia Patients using in Silico Method
Open Access
- 11 February 2026
- journal article
- Published by F1000 Research Ltd in F1000Research
- Vol. 15, 235
Abstract
Introduction Indonesia is located along the “Thalassemia Belt,” a hotspot region for hemoglobinopathies, including beta thalassemia, with approximately 3–10% of the Indonesian population diagnosed with this disease. Thalassemia was diagnosed using the Hb analysis results. However, the single nucleotide variant (SNVs) database for the Indonesian population, which leads to β-thalassemia disease, has not been extensively studied. This study aimed to profile the genetic variations in Indonesian β-thalassemia patients and conduct in silico characterization of their functional effects. Methods Twenty thalassemia patients were recruited for this study. The sample collected from the respondents was whole blood in EDTA tubes, with a minimum collection time of 14 days after blood transfusion. Genomic DNA (gDNA) was extracted using a commercial kit, directly amplified using Polymerase Chain Reaction (PCR) with specific primers for β-globin and sequenced using Sanger Sequencing. All variants located in exon regions were analyzed using FinchTV, BioEdit, and Biovia Discovery Studio to determine their functional impact. Results Ten reported pathogenic variants were observed along with one rare variant. Genetic variations found according to its common name and nomenclature based on Human Genome Variation Society (HGVS) are IVS1nt.1 (HGVS: c.92+1G>A), IVS1nt.1 (HGVS: c.92+1G>T), IVS1nt.2 (HGVS: c.92+2G>T), IVS1nt.5 (HGVS: c.92+5G>C), IVS2nt.654 (HGVS: c.316-197C>T), Cd15 (HGVS: c.47G>A), Cd26 (HGVS: c.79G>A), Cd30 (HGVS: c.92G>C), Cd41/42 (c.126_129delCTTT), and Cd35 (HGVS: c.110delC). Analysis of amino acid interactions revealed that disease-causing mutations were clinically relevant in each subject. Conclusions This study has bioinformatically proven the effect of genetic mutations and predicted their effect on amino acid interactions. These findings contribute to the study of Indonesian thalassemia and require further research.Keywords
Funding Information
- Fakultas Kedokteran, Universitas Indonesia (NKB-1120/UN2.RST/HKP.05.00/2022)
This publication has 11 references indexed in Scilit:
- Recommendations for clinical interpretation of variants found in non-coding regions of the genomeGenome Medicine, 2022
- Agarose Gel Electrophoresis to Assess PCR Product Yield: Comparison with Spectrophotometry, Fluorometry and qPCRBioTechniques, 2022
- Thalassemia in IndonesiaHemoglobin, 2022
- Molecular Spectrum of β-Thalassemia Mutations in Central to Eastern ThailandHemoglobin, 2021
- An insight into Indonesian current thalassaemia care and challengesISBT Science Series, 2020
- Combined use of gap-PCR and next-generation sequencing improves thalassaemia carrier screening among premarital adults in ChinaJournal of Clinical Pathology, 2020
- Molecular Characterization of β-Thalassemia Mutations in Central VietnamHemoglobin, 2017
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015
- A wider molecular spectrum of β‐thalassaemia in MyanmarBritish Journal of Haematology, 2002
- Molecular Analysis of β-Thalassemia in VietnamHemoglobin, 2000